FMR LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$5,184
+92.2%
2,225
+96.4%
0.00%
Q2 2023$2,697
-35.3%
1,133
-50.0%
0.00%
Q1 2023$4,170
+93.7%
2,266
+100.0%
0.00%
Q4 2022$2,153
-99.7%
1,133
-99.7%
0.00%
Q3 2022$816,000
-24.2%
381,318
+0.3%
0.00%
Q2 2022$1,076,000
-84.3%
380,185
-76.9%
0.00%
-100.0%
Q1 2022$6,848,000
-19.7%
1,642,2850.0%0.00%0.0%
Q4 2021$8,523,000
-13.4%
1,642,285
+9.3%
0.00%0.0%
Q3 2021$9,838,000
-28.4%
1,501,988
-27.5%
0.00%0.0%
Q2 2021$13,748,000
+15.9%
2,070,4880.0%0.00%0.0%
Q1 2021$11,864,000
+1077.0%
2,070,488
+1736.1%
0.00%
Q4 2020$1,008,000
+60.5%
112,767
+108.9%
0.00%
Q3 2020$628,000
-55.5%
53,994
-38.6%
0.00%
Q2 2020$1,411,000
+11.0%
88,008
-58.5%
0.00%
Q1 2020$1,271,000
-54.6%
212,1080.0%0.00%
Q4 2019$2,800,000
-27.5%
212,108
-31.8%
0.00%
Q3 2019$3,864,000
-35.8%
311,148
-16.8%
0.00%
-100.0%
Q2 2019$6,018,000373,8000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders